EBSCO Health

Print PageSend to a Friend
Health Library Home>Disease, Condition, & Injury Fact Sheets>Article

Retinitis Pigmentosa

(RP)

Definition

Retinitis pigmentosa (RP) is a group of inherited eye diseases that often leads to severe visual problems. The retina is a layer of light-sensitive tissue that lines the back of the eye. It converts visual images that we see into nerve impulses that it sends to the brain. This disorder is named for the irregular clumps of black pigment that usually occur in the retina with this disease.

Some types of RP are associated with other inherited conditions.

Causes

Many types of RP are caused by a genetic mutation. Some cases occur sporadically.

Vision loss occurs when light-sensitive and pigment cells in the retina gradually break down. There are 2 types of cells in the retina:

  • Cones—These cells are found mostly in the center of the retina. Cones are needed for central vision and to see colors.
  • Rods—Located mostly away from the center, rods respond to dim light. They provide night and peripheral vision.

In most forms of retinitis pigmentosa, the rods die. Vision, thus, becomes impaired at night. The ability to see things off to the side while looking ahead also decreases.

In some forms of RP, the cones are lost. In those cases, central and color vision suffers. Vision loss usually progresses over a period of many years.

Risk Factors

RP is more common in males and in those with family members who have it.

Symptoms

Reduction of vision is usually first noted in childhood or early adulthood. The disease gradually worsens. After a number of years, vision loss may become severe.

Symptoms vary, depending on the type of retinal cell that is affected. Both eyes often experience similar vision loss.

In general, RP may cause:

  • Night blindness (the most common symptom)
  • Decreased peripheral vision/visual field narrows, often called "tunnel vision"
  • Eyes take longer to adjust to dim lighting or are slow to make adjustment from bright sun to indoor lighting
  • Trouble seeing in foggy or rainy weather
  • Difficulty seeing colors, especially blue
  • Visual loss, partial or complete, usually gradually progressive
  • Clumsiness from lack of sight, especially in narrow spaces such as doorways

Blurry vision from cataracts may complicate RP later in the disease.

Diagnosis

You will be asked about your symptoms and medical history. An eye exam will be done. You may be referred to an eye specialist for further treatment.

Vision tests may include:

  • Visual field testing—To check peripheral vision, which is how well you see off to your side, rather than directly ahead, without moving your eyes.
  • Visual acuity—Checks how well you can see progressively smaller objects, usually a row of letters or numbers.
  • Dark adaptometry—Tests how your vision adapts to darkness.
  • Color testing—Determines how well you can differentiate colors.
  • Electroretinogram (ERG)—A test to measure electrical activity in the eye. This test identifies the loss of cell function in the retina and is used to track progression of the disease.
  • Optical coherence tomography—Imaging to get highly detailed pictures of your retina

Treatment

There is no effective treatment or cure for RP. Treatment aims to help you function with the vision that you have. Your doctor can counsel you about expected patterns of vision loss based on the type of RP you have. Recommendations include:

Vitamin A

One study implied that large doses of vitamin A can slow the progression of RP by approximately 2% per year. However, the use of this finding is controversial. For one, it is a very mild effect given the large dose. Secondly, there may be side effects of such large doses of vitamin A. Always talk to your doctor before taking any supplements.

Light Avoidance

Although no direct link has been established, it is generally recommended that everybody, especially those with disorders such as RP, wear dark UV (ultraviolet)-protected sunglasses and a wide-brimmed hat in bright, sunny conditions, such as while skiing or at the beach.

Low-vision Aids

These may include the following:

  • Magnifying glasses
  • Electronic magnifiers, which project an enlarged image onto a screen
  • Night vision scopes, which enlarge distant objects under conditions of low light
  • Lenses for distant vision (eyeglasses or contacts)

Some community organizations offer classes to help people with vision loss adjust and learn how to use vision aids. If you are considered legally blind, you are entitled to many low-vision services at no cost.

Prevention

Once RP has been inherited there are no known ways to prevent the disorder from occurring. If you have RP or have a family history of the disorder, you can talk to a genetic counselor when deciding to have children.

RESOURCES:

Prevent Blindness America
http://www.preventblindness.org

RP International
http://www.rpinternational.org

CANADIAN RESOURCES:

Canadian Association of Optometrists
http://www.opto.ca

Canadian National Institute for the Blind
http://www.cnib.ca

REFERENCES:

Facts About Retinitis Pigmentosa. National Eye Institute website. Available at: https://nei.nih.gov/health/pigmentosa/pigmentosa_facts. Updated May 2014. Accessed December 15, 2017.

Retinitis pigmentosa. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T116916/Retinitis-pigmentosa. Updated August 2, 2017. Accessed December 15, 2017.

Retinitis pigmentosa. Merck Manual Professional Version website. Available at: http://www.merckmanuals.com/professional/eye-disorders/retinal-disorders/retinitis-pigmentosa. Updated January 2017. Accessed December 15, 2017.

Low vision aids and low vision rehabilitation. Eye Smart—American Academy of Ophthalmology website. Available at: http://www.geteyesmart.org/eyesmart/diseases/low-vision-aids-rehabilitation.cfm. Updated January 25, 2017. Accessed December 15, 2017.

What is retinitis pigmentosa? Eye Smart—American Academy of Ophthalmology website. Available at: http://www.geteyesmart.org/eyesmart/diseases/retinitis-pigmentosa.cfm. Updated September 1, 2017. Accessed December 15, 2017.

Last reviewed November 2018 by EBSCO Medical Review Board Michael Woods, MD, FAAP